From where did you pull out your numbers, $7.00-$7.75? Did they just come to you in a dream? Give us a break with that nonsense you have no idea what it is worth and it is a rather odd post for an alleged long.
Not surprising that the only response you can come up with is regarding paragraphs. You appear to have no concept of facts and your writing skills are quite minimal. However, if these blog posts of yours give you a sense of worth I guess that is a good thing.
The blog post appears to have been written by a kid in junior high school. Broken sentences, poor transitions, disjointed arguments and minimal foundation for conclusions. Seeking Alpha appears to have no standards. Particularly troublesome is the argument that the arrangement with MD Anderson does not change the "dynamics". The writer appears to have no understanding of who MD Anderson is and their standing in the cancer research community. The fact ZIOP was selected over all others to work with them is an extraordinary game changer. Anyone who thinks $15-$20 million a year for that relationship is a steep price must be a dult who has no grasp of the technology involved or the significant value to ZIOP. Moreover, the use of a 5 year chart on a developing biotech is simply absurd. Does the writer have any understanding of what drives biotech stocks and their valuations. Notably, the blog fails to mention the likelihood of further partnerships with pharma or big biotech which will add further value and justify a much higher valuation and which have been alluded to by senior managment. Lastly, anyone who characterizes a significant investment by Bill Miller as a "plug" truly has contempt for reality and exposes the writer's motives of driving down the share price to benefit his likely meaningless collection of puts.
Run it down? The stock closed a lousy 16 cents off its high of the day. Looks more like traders taking some profit before the weekend.
Actually if we are going to see bad news it would be more likely to occur once after hours trading closes tonight. News released over the weekend particularly Sunday nights is frequently good.
About 7,000 call contracts traded compared to about 700 put contracts for April. Traders appear to be betting the stock is going up.
If you have been trading for 20 years you know over the last several years we have a biotech sell off every six months for a few days and then the stocks recover and move to new highs. Don't expect this to be very different, the sky is not falling.
Appears the only thing holding up this historical underachiever was the possibility of a JDSU deal. Now that there is noise a deal may not happen until the 3rd quarter the stock is falling apart.
Valid points to some extent, but when statements are made like that with teases as to time frames and months pass by without their substance coming to fruition there is pause for concern. The statements were ill advised and were not helpful and without doubt many are frustrated and are taking profits.
since we heard "days, weeks months ahead" from Kirk regarding partnership news.
2 months since Lewis and "soon"
Perhaps the time has come to deliver on these statements.